Diagnosis and Management of Male Breast Cancer

Lanitis, Sophocles; Rice, Alexandra J.; Vaughan, Alexander; Cathcart, Paul; Filippakis, George; Al Mufti, Ragheed; Hadjiminas, Dimitri J.
November 2008
World Journal of Surgery;Nov2008, Vol. 32 Issue 11, p2471
Academic Journal
Male breast cancer (MBC) is rare with an incidence of 1% of all breast cancers. The evidence about the treatment is derived from the data on the management of the female breast cancer because conduction of randomized, controlled trials is impossible due to the rarity of the disease. In this study, we review the special features, overall management, diagnosis, and treatment of patients with MBC managed under our care with a brief review of the current literature. During the period 1998 to 2006, we managed 1103 new patients with breast cancer in St Mary’s Hospital. Among these, 14 patients were men. We retrospectively reviewed the case notes, histology, and follow-up notes of all the newly diagnosed patients with MBC. In this series, 28.6% had only in situ disease. Moreover, in 78.6% there was an in situ component present. One patient was found to have a cancer on the microdochectomy specimen after an operation for single duct nipple discharge, and in a second patient the cancer was found in the gynecomastia operation specimen. All ten invasive tumors were estrogen receptor positive (ER +ve), whereas eight were progesterone receptor positive (PgR +ve). With a median follow-up of 35 months, there was one locoregional recurrence and one disease-associated death. In situ cancer may not be as rare as previously reported among patients with MBC. Increased patient awareness and early assessment by a specialist is a key to early diagnosis and improved outcomes.


Related Articles

  • Male breast cancer - own experience. Boratyn-Nowicka, Agnieszka; Gabrys, Dorota; Nowara, Elzbieta // Central European Journal of Urology;Jun2009, Vol. 62 Issue 2, p89 

    Introduction. Male breast cancer comprises about 1% of all breast cancer cases. The advanced stage of the disease at the time of diagnosis is connected with shorter overall survival rates when compared to female patients. We estimate 1, 2, 3, and 5-year overall survival rates in male breast...

  • Initiating treatment quickly after a breast-cancer diagnosis can significantly improve survival.  // Women's Health Advisor;Mar2013, Vol. 17 Issue 3, p2 

    The article focuses on a research which states that initiation of the treatment after the diagnosis of breast cancer may increase the survival chances of patients.

  • Letters to the Editor. Pereira Sampaio, Giorge; Vieira Koch, Melissa; Boechat, Márcia; Esteves Matos, Viviane; Sarmet Moreira Damas Dos Santos, Alair Augusto // Radiologia Brasileira;set/out2016, Vol. 49 Issue 5, p344 

    The article discusses a research conducted on the diagnosis and treatment of a male patient suffering from breast cancer with splenic metastasis.

  • Male Breast Cancer. Yalaza, Metin; İnan, Aydın; Bozer, Mikdat // Meme Sagligi Dergisi / Journal of Breast Health;Jan2016, Vol. 12 Issue 1, p1 

    Male breast cancer (MBC) is a rare disease, accounting for less than 1% of all breast cancer diagnoses worldwide. Although breast carcinomas share certain characteristics in both genders, there are notable differences. Most studies on men with breast cancer are very small. Thus, most data on...

  • Risking 'Safety': Breast Cancer, Prognosis, and the Strategic Enterprise of Life. Ehlers, Nadine // Journal of Medical Humanities;Mar2016, Vol. 37 Issue 1, p81 

    Living in modern biopolitical risk culture might be seen as synonymous with living in prognosis time, in the sense that risk of illness is endlessly forecast (prognosticated) in the broad social arena. 'Safety,' in this context, is framed as the anticipatory guarding against risk or disease in...

  • Does Increased Detection Account for the Rising Incidence of Breast Cancer? Liff, Jonathan M.; Sung, John F. C.; Wong-Ho Chow; Greenberg, Raymond S.; Flanders, W. Dana // American Journal of Public Health;Apr91, Vol. 81 Issue 4, p462 

    Background: The incidence of breast cancer has been increasing over time in the United States. Methods: To determine tho role of screening in this increase, trends in the incidence of in situ and invasive carcinoma of the breast were evaluated using records of the metropolitan Atlanta SEER...

  • Screening and management of osteoporosis in breast cancer patients on aromatase inhibitors. Gibson, Kelli; O'Bryant, Cindy L. // Journal of Oncology Pharmacy Practice;Sep2008, Vol. 14 Issue 3, p139 

    Objective. Breast cancer patients are at an increased risk of osteoporosis due to age, cancer, chemotherapy, and aromatase inhibitor therapy. This retrospective review determined if patients treated with aromatase inhibitors received appropriate screening and management for osteoporosis. Design....

  • Having cancer made Kylie Minogue endearing.  // Radio & Music;5/18/2015, p1 

    The article reports that Australian singer Kylie Minogue thinks that having breast cancer made her lovable. It reveals that the singer was diagnosed with cancer in 2005 and was given all clear by the doctors after nine-years of treatment. It mentions that the disease has changed the way the...

  • The fluctuating incidence, improved survival of patients with breast cancer, and disparities by age, race, and socioeconomic status by decade, 1981–2010. Lu, Guanming; Li, Jie; Wang, Shuncong; Pu, Jian; Sun, Huanhuan; Wei, Zhongheng; Ma, Yanfei; Wang, Jun; Ma, Haiqing // Cancer Management & Research;Oct2018, Vol. 10, p4899 

    Purpose: Breast cancer is the most commonly diagnosed cancer and the leading cause of cancer-related deaths among women worldwide. However, the data on breast cancer incidence and survival over a long period, especially the dynamic changes in the role of race and socioeconomic status (SES), are...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics